Daily moderate alcohol consumption increases serum paraoxonase activity; a diet-controlled, randomised intervention study in middle-aged men

Atherosclerosis

Volumn 147, Issue 2, 1999, Pages 405-410

  Van Der Gaag, Martijn S ^a   Van Tol, Arie ^b   Scheek, Leo M ^b   James, Richard W ^c   Urgert, Rob ^a   Schaafsma, Gertjan ^d   Hendriks, Henk F J ^a  

^a TNO   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^c Div of Endocrinology and Diabetes   (Switzerland)

^d WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

Alcohol; Beer; Coronary heart disease; High density lipoprotein; Paraoxonase; Spirits; Wine

Indexed keywords

APOLIPOPROTEIN A1; ARYLDIALKYLPHOSPHATASE; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; GENOTYPE; HUMAN; HUMAN EXPERIMENT; ISCHEMIC HEART DISEASE; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK; WINE;

ADULT; ALCOHOL DRINKING; APOLIPOPROTEINS A; ARYLDIALKYLPHOSPHATASE; CORONARY DISEASE; CROSS-OVER STUDIES; DIET; ESTERASES; HUMANS; INTERVENTION STUDIES; LIPOPROTEINS, HDL; MALE; MIDDLE AGED; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY;

EID: 0032756401     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(99)00243-9     Document Type: Article

References (35)

1. Klatsky A.L., Friedman G.D., Siegelaub A.B. Alcohol use and cardiovascular disease: the Kaiser-Permanente experience. Circulation. 64:1981;32-41.
2. Maclure M. Demonstration of deductive meta-analysis: ethanol intake and risk of myocardial infarction. Epidemiol. Rev. 15:1993;328-351.
3. Keil U., Chambless L.E., Doring A. The relation of alcohol intake to coronary heart disease and all-cause mortality in a beer-drinking population. Epidemiology. 8:1997;150-156.
4. Yuan J.M., Ross R.K., Gao Y.T., Henderson B.E., Yu M.C. Follow up study of moderate alcohol intake and mortality among middle aged men in Shanghai, China. Br. Med. J. 314:1997;18-23.
5. Camargo C.A., Hennekens C.H., Gaziano J.M. Prospective study of moderate alcohol consumption and mortality in US male physicians. Arch. Intern. Med. 157:1997;79-85.
6. Grønbæk M., Deis A., Sørensen T.A., Becker U., Schnorht P., Gensen G. Mortality associated with moderate intake of wine, beer, or spirits. Br. Med. J. 310:1995;1165-1169.
7. Klatsky A.L., Armstrong M.A., Friedman G.D. Red wine, white wine, liquor, beer, and risk for coronary artery disease hospitalization. Am. J. Cardiol. 80:1997;416-420.
8. Rimm E.B., Klatsky A.L., Grobbee D., Stampfer M.J. Review of moderate alcohol consumption and reduced risk of coronary heart disease: is the effect due to beer, wine, or spirits? Br. Med. J. 312:1996;731-736.
9. Gaziano J.M., Buring J.E., Breslow J.L. et al. Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction. N. Eng. J. Med. 329:1993;1829-1834.
10. La Du B. Human serum paraoxonase/arylesterase. Pharmacogenetics of Drug Metabolism. New York: Pergamon Press, 1992, p. 51-91.
11. Mackness M.I., Arrol S., Mackness B., Durrington P.N. Alloenzymes of paraoxonase and effectiveness of high-density lipoproteins in protecting low-density lipoprotein against lipid peroxidation. Lancet. 349:1997;851-852.
12. Mackness B., Mackness M.I., Arrol S., Turkie W., Durrington P.N. Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipoprotein against low density lipoprotein oxidative modification. FEBS. Lett. 423:1998;57-60.
13. Aviram M., Rosenblat M., Bisgaier C.L., Newton R.S., Primo-Parmo S.L., La Du B.N. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase. J. Clin. Invest. 101:1998;1581-1590.
14. Watson A.D., Berliner J.A., Hama S.Y. et al. Protective effect of high density lipoprotein associated paraoxonase-inhibition of the biological activity of minimally oxidized low density lipoprotein. J. Clin. Invest. 96:1995;2882-2891.
15. Shih D.M., Gu L., Xia Y. et al. Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis. Nature. 394:1998;284-287.
16. Hernandez AF, Pla A, Valenzuela A, Gil F, Hougen HP, Villanueva E. Paraoxonase activity in human pericardial fluid: its relationship to coronary artery disease. Int J Legal Med 1993;105:321-324.
17. McElveen J., Mackness M.I., Colley C.M., Peard T., Warner S., Walker C.H. Distribution of paraoxon hydrolytic activity in the serum of patients after myocardial infarction. Clin. Chem. 32:1986;671-673.
18. Mackness M.I., Mackness B., Durrinton P.N. et al. Paraoxonase and coronary heart disease. Curr. Opin. Lipidiol. 9:1998;319-323.
19. Mackness B., Mackness M.I., Arrol S., Turkie W., Durrington P.N. Effect of the molecular polymorphisms of human paraoxonase (PON1) on the rate of hydrolysis of paraoxon. Br. J. Pharmacol. 122:1997;265-268.
20. Shih D.M., Gu L., Hama S. et al. Genetic-dietary regulation of serum paraoxonase expression and its role in atherogenesis in a mouse model. J. Clin. Invest. 97:1996;1630-1639.
21. Hayek T., Fuhrman B., Vaya J. et al. Reduced progression of atherosclerosis in apolipoprotein E-deficient mice following consumption of red wine, or its polyphenols quercetin or catechin, is associated with reduced susceptibility of LDL to oxidation and aggregation. Arterioscler. Thromb. Vasc. Biol. 17:1997;2744-2752.
22. Schofield W.N. Predicting basal metabolic rate, new standards and review of previous work. Hum. Nutr. Clin. Nutr. C. 39(1):1985;5-41.
23. Rumpler W.V., Rhodes D.G., Baer D.J. et al. Energy value of moderate alcohol consumption by humans. Am. J. Clin. Nutr. 64:1996;108-114.
24. Westerterp K.R. Effect of moderate alcohol consumption on energy expenditure. Alc. Res. 1:1996;187-189.
25. Gan K.N., Smolen A., Eckerson H.W., La Du B.N. Purification of human serum paraoxonase/arylesterase. Evidence for one esterase catalyzing both activities. Drug. Metab. Disp. 19:1991;100-106.
26. Blatter Garin M., Abbott C., Messmer S. et al. Quantification of human serum paraoxonase by enzyme-linked immunoassay: population differences in protein concentrations. Biochem. J. 304:1994;549-554.
27. La Du B.N., Eckerson H.W. The polymorphic paraoxonase/arylesterase isozymes of human serum. Fed. Proc. 43:1984;2338-2341.
28. Hendriks H.F.J., Veenstra J., Velthuis-te Wierik E.J.M., Schaafsma G., Kluft C. Effect of moderate dose of alcohol with evening meal on fibrinolytic factors. Br. Med. J. 308:1994;1003-1006.
29. Durrington P.N., Mackness M.I., Bhatnagar D. et al. Effects of two different fibric acid derivatives on lipoproteins, cholesteryl ester transfer, fibrinogen, plasminogen activator inhibitor and paraoxonase activity in type IIb hyperlipoprotinaemia. Atherosclerosis. 138:1998;217-225.
30. James R.W., Blatter Garin M., Calabresi L. et al. Modulated serum activities and concentrations of paraoxonase in high density lipoprotein deficiency states. Atherosclerosis. 139:1998;77-82.
31. De Rijke Y.B., Demacker P.N.M., Assen N.A., Sloots L.M., Katan M.B., Stalenhoef A.F.H. Red wine consumption does not affect oxidizability of low-density lipoproteins in volunteers. Am. J. Clin. Nutr. 63:1996;329-334.
32. Kinosian B., Glick H., Preiss L., Puder K.L. Cholesterol and coronary heart disease: predicting risks in men by changes in levels and ratios. J. Invest. Med. 43:1995;443-450.
33. Van Tol A., Groener J.E.M., Scheek L.M. et al. Induction of net mass lipid transfer reactions in plasma by wine consumption with evening dinner. Eur. J. Clin. Invest. 25:1995;390-395.
34. Hendriks H.F.J., Veenstra J., Van Tol A., Groener J.E.M., Schaafsma G. Moderate doses of alcoholic beverages with dinner and postprandial high density lipoprotein composition. Alc. Alcoholism. 4:1998;403-410.
35. Mackness M.I., Durrington P.N. HDL, its enzymes and its potential to influence lipid peroxidation. Atherosclerosis. 115:1995;243-253.